Compare WAFU & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WAFU | VNRX |
|---|---|---|
| Founded | 1999 | N/A |
| Country | China | United States |
| Employees | N/A | 75 |
| Industry | Other Consumer Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8M | 6.3M |
| IPO Year | 2017 | 2012 |
| Metric | WAFU | VNRX |
|---|---|---|
| Price | $1.41 | $0.19 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.62 |
| AVG Volume (30 Days) | 24.1K | ★ 966.3K |
| Earning Date | 07-31-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | N/A | $57.67 |
| Revenue Next Year | N/A | $240.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $1.22 | $0.13 |
| 52 Week High | $3.06 | $3.26 |
| Indicator | WAFU | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.98 | 43.23 |
| Support Level | $1.32 | $0.15 |
| Resistance Level | $1.53 | $0.72 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 15.00 | 63.52 |
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.